We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1908:HKEXC&D International Investment Group Limited Analysis

Data as of 2026-03-16 - not real-time

HK$14.10

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

C&D International Investment Group (1908.HK) is trading at HK$14.1, well below its 20‑day SMA of 14.81, 50‑day SMA of 15.26 and 200‑day SMA of 16.37, indicating a bearish price trend. The 14‑day RSI sits at 38.7, hinting at mild oversold conditions but not yet in the extreme zone. MACD remains in a bearish alignment with the histogram negative, reinforcing downside momentum. Nonetheless, the stock enjoys a robust support level around 13.80 and a clear resistance near 16.05. Volume has been increasing, suggesting accumulating interest despite the technical weakness. The market price is also far beneath the DCF‑derived fair value of 27.84, implying a potential upside of roughly 49%.
Fundamentally, the company trades at a trailing PE of 5.55 versus an industry average of 32.51, and a price‑to‑book of 0.95, underscoring deep value. A dividend yield of 8.44% with a payout ratio under 50% signals sustainable income for shareholders. The balance sheet shows ample cash of HK$58.8 bn offsetting debt of HK$92.7 bn, resulting in a high debt‑to‑equity of 86.7 but manageable given the cash cushion. Volatility is elevated at over 35% for the past 30 days, while beta is effectively neutral at 0.10, indicating price swings are driven more by company‑specific factors than market moves. Real‑estate development in China carries medium to high regulatory and sector risk, which must be weighed against the attractive valuation. Overall, the stock presents a compelling value case with strong dividend appeal, albeit tempered by sector and liquidity considerations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support at 13.80
  • bearish technical indicators (RSI, MACD)
  • high dividend yield provides cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant valuation gap to DCF fair value
  • sustainable dividend payout
  • strong cash position relative to debt

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • potential upside of ~49% per DCF
  • low price-to-book and PE vs peers
  • stable earnings and dividend track record

Key Metrics & Analysis

Financial Health

Revenue Growth4.30%
Profit Margin3.39%
P/E Ratio5.6
ROE6.36%
ROA1.47%
Debt/Equity86.68
P/B Ratio0.9
Op. Cash FlowHK$19.2B
Free Cash FlowHK$5.6B
Industry P/E32.5

Technical Analysis

TrendBearish
RSI38.7
SupportHK$13.80
ResistanceHK$16.05
MA 20HK$14.81
MA 50HK$15.26
MA 200HK$16.37
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueHK$27.84
Target PriceHK$21.03
Upside/Downside49.13%
GradeUndervalued
TypeValue
Dividend Yield8.44%

Risk Assessment

Beta0.00
Volatility35.18%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.